Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. Amazon Location Service.

Clinical trial site

Virginia Mason Medical Center

Virginia Mason Medical Center in Seattle, Washington, United States is listed as a site for 502 registered clinical trials, 115 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 502
Ongoing 115

This page covers the site record Virginia Mason Medical Center in Seattle, Washington, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Virginia Mason Medical Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 502 trials counted.

  • Phase 1 23 trials
  • Phase 1/2 24 trials
  • Phase 2 126 trials
  • Phase 2/3 21 trials
  • Phase 3 190 trials
  • Phase 4 10 trials
  • Not applicable 53 trials
  • Observational 52 trials
  • Expanded access 2 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 115 trials
  • Completed 295 trials
  • Terminated 69 trials
  • Other 23 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Unknown)

Top of scale: 36

1992: 1 trials (Observational 1) 1994: 4 trials (Phase 3 3, Phase 1/2 1) 1995: 1 trials (Phase 1/2 1) 1996: 2 trials (Phase 3 2) 1997: 2 trials (Phase 2 1, Phase 1/2 1) 1998: 10 trials (Phase 3 6, Phase 2 2, Phase 1/2 1, Phase 1 1) 1999: 3 trials (Phase 3 1, Phase 2 1, Phase 1/2 1) 2000: 13 trials (Not applicable 1, Phase 3 6, Phase 2 4, Phase 1/2 2) 2001: 12 trials (Not applicable 1, Phase 4 1, Phase 3 2, Phase 2 5, Phase 1/2 2, Phase 1 1) 2002: 6 trials (Not applicable 1, Phase 3 2, Phase 2/3 1, Phase 2 2) 2003: 7 trials (Phase 3 4, Phase 2 3) 2004: 7 trials (Observational 1, Phase 3 2, Phase 2 4) 2005: 6 trials (Observational 1, Not applicable 1, Phase 3 3, Phase 1/2 1) 2006: 11 trials (Observational 1, Phase 3 5, Phase 2 4, Phase 1/2 1) 2007: 24 trials (Other 1, Observational 3, Phase 3 10, Phase 2/3 2, Phase 2 7, Phase 1 1) 2008: 17 trials (Observational 2, Not applicable 2, Phase 3 5, Phase 2/3 1, Phase 2 6, Phase 1 1) 2009: 17 trials (Observational 3, Not applicable 1, Phase 3 10, Phase 2 2, Phase 1 1) 2010: 17 trials (Observational 2, Phase 3 8, Phase 2 3, Phase 1/2 2, Phase 1 2) 2011: 31 trials (Observational 3, Phase 4 1, Phase 3 10, Phase 2 15, Phase 1/2 1, Phase 1 1) 2012: 26 trials (Observational 4, Not applicable 2, Phase 4 1, Phase 3 11, Phase 2/3 1, Phase 2 5, Phase 1/2 1, Phase 1 1) 2013: 22 trials (Observational 6, Not applicable 1, Phase 3 6, Phase 2 7, Phase 1/2 1, Phase 1 1) 2014: 36 trials (Observational 5, Not applicable 6, Phase 3 12, Phase 2/3 5, Phase 2 7, Phase 1/2 1) 2015: 28 trials (Observational 5, Not applicable 3, Phase 4 1, Phase 3 13, Phase 2 4, Phase 1 2) 2016: 21 trials (Observational 2, Not applicable 6, Phase 4 2, Phase 3 6, Phase 2 4, Phase 1/2 1) 2017: 35 trials (Observational 2, Not applicable 6, Phase 4 2, Phase 3 14, Phase 2/3 1, Phase 2 10) 2018: 20 trials (Observational 2, Not applicable 1, Phase 3 7, Phase 2/3 2, Phase 2 4, Phase 1 4) 2019: 21 trials (Observational 1, Not applicable 5, Phase 3 10, Phase 2/3 1, Phase 2 4) 2020: 15 trials (Observational 2, Not applicable 2, Phase 3 6, Phase 2/3 1, Phase 2 3, Phase 1/2 1) 2021: 15 trials (Observational 2, Not applicable 5, Phase 3 4, Phase 2/3 2, Phase 2 1, Phase 1 1) 2022: 17 trials (Observational 1, Not applicable 3, Phase 3 3, Phase 2/3 2, Phase 2 6, Phase 1/2 1, Phase 1 1) 2023: 19 trials (Observational 2, Not applicable 2, Phase 4 1, Phase 3 6, Phase 2 4, Phase 1/2 2, Phase 1 2) 2024: 14 trials (Observational 1, Not applicable 1, Phase 4 1, Phase 3 7, Phase 2/3 1, Phase 2 3) 2025: 12 trials (Not applicable 3, Phase 3 4, Phase 2/3 1, Phase 1/2 2, Phase 1 2)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 2
2025 12
2024 14
2023 19
2022 17
2021 15
2020 15
2019 21
2018 20
2017 35

Showing 10 of 34 years.

Start your 14-day trial Email me all 34 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 502 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 129 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 306 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF